Explore how organoids are unlocking new possibilities in modern drug discovery by improving disease modelling within ...

VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAM) 3d human cellular models for preclinical safety, today announced revenue ...

Small-cap healthcare and emerging growth stocks continue to generate investor interest as multiple companies announced ...

Dr Lovi Raj Gupta, pro vice-chancellor, Lovely Professional University, explains how aspiring professionals can equip ...

NTHI to provide ongoing news coverage of expected upcoming catalysts and events as well as market outreach services. This should not be construed as financial or investment advice. Trading involves ...

Gnosis Freight CRO Michael Rentz breaks down what operational-grade data infrastructure actually requires, and what shippers ...

ServiceNow (NOW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming ...

Discover how the next generation of DMTA is creating a future-ready drug discovery engine through AI and automation.

Medicare spends over $1 trillion a year and still can't keep most providers from drowning in administrative overhead while ...

I connected with experts to find out where our air quality is headed, and if air purifiers are the breath of fresh air we ...

Discover 10 remote entry-level jobs that pay $50 an hour or more. These flexible roles let you earn great money from home ...

Azitra, Inc. , a clinical stage biopharmaceutical company focused on developing innovative therapies for precision ...